Merck & Company ( ($MRK) ) has shared an announcement. On May 22, 2026, Merck & Co., Inc. completed an underwritten public offering of multiple tra......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Merck & Company (MRK) and BioInvent International AB......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Merck & Company (MRK) with bull......

Exchange-traded funds (ETFs) remain a popular investment choice as investors seek diversification, lower costs, and exposure to fast-growing sector......

Exchange-traded funds (ETFs) remain a popular investment choice as investors seek diversification, lower costs, and exposure to fast-growing sector......

In a report released today, from Jefferies maintained a Buy rating on Merck & Company, with a price target of $138.00. In addition to Jefferies, Me......

In a report released today, Falko Friedrichs from Deutsche Bank maintained a Hold rating on Merck KGaA, with a price target of €125.00. According t......

Exchange-traded funds (ETFs) remain a popular choice for investors seeking diversified exposure, lower risk, and long-term growth potential. From A......

UBS analyst Matthew Weston maintained a Buy rating on Merck KGaA today and set a price target of €150.00. According to TipRanks, Weston is ranked #......

J.P. Morgan analyst Richard Vosser maintained a Buy rating on Merck KGaA today and set a price target of €150.00. According to TipRanks, Vosser is ......